Skystar Bio-Pharmaceutical CO (SKBI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,142 | 11,322 | 7,049 | 5,888 | 11,699 |
| Receivables | 11,010 | 10,011 | 3,392 | 6,537 | 4,874 |
| Inventories | 25,904 | 22,962 | 14,851 | 7,202 | 4,075 |
| Income taxes - deferred | 364 | N/A | N/A | N/A | N/A |
| Other current assets | 0 | 1,079 | 964 | 8,040 | 0 |
| TOTAL | $88,615 | $71,652 | $58,904 | $44,741 | $32,548 |
| Non-Current Assets | |||||
| PPE Net | 28,269 | 28,868 | 28,377 | 22,613 | 8,829 |
| Intangibles | 5,237 | 5,320 | 5,674 | 6,044 | 1,860 |
| Other Non-Current Assets | 14,102 | 9,920 | 10,922 | 7,851 | 17,369 |
| TOTAL | $47,608 | $44,107 | $44,972 | $36,508 | $28,059 |
| Total Assets | $136,223 | $115,759 | $103,877 | $81,249 | $60,607 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 10,641 | 4,444 | 7,366 | 3,026 | 330 |
| Accounts payable and accrued liabilities | 9,771 | 8,392 | 6,322 | 2,100 | 1,215 |
| Other current liabilities | 3,239 | 2,420 | 1,489 | 1,478 | 1,788 |
| TOTAL | $24,966 | $17,206 | $15,337 | $7,354 | $4,055 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 1,270 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 63 | 6 | 43 | 1,420 | 1,539 |
| TOTAL | $865 | $2,339 | $437 | $2,406 | $2,639 |
| Total Liabilities | $25,831 | $19,544 | $15,774 | $9,759 | $6,694 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 7,605 | 7,605 | 7,162 | 7,162 | 7,098 |
| Common Shares | 8 | 8 | 7 | 7 | 7 |
| Retained earnings | 60,943 | 50,413 | 44,200 | 30,543 | 16,454 |
| Other shareholders' equity | 11,811 | 8,774 | 8,111 | 5,156 | 2,872 |
| TOTAL | $110,393 | $96,215 | $88,103 | $71,490 | $53,913 |
| Total Liabilities And Equity | $136,224 | $115,759 | $103,877 | $81,249 | $60,607 |